SCHEMBL7486197

SCHEMBL7486197

COc1ccc(Cl)cc1-c1c(N)c(=O)[nH]c2cc([N+](=O)[O-])ccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.45
HTT P42858 1/20 0.45
TDP1 Q9NUW8 2/20 0.44
CYP2C9 P11712 1/20 0.43
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41
ROCK2 O75116 1/20 0.41
MAP4K4 O95819 1/20 0.41
LCK P06239 1/20 0.41
CSF1R P07333 1/20 0.41
PIM1 P11309 1/20 0.41
RPS6KB1 P23443 1/20 0.41
CDK2 P24941 1/20 0.41
MAPK1 P28482 1/20 0.41
EPHA2 P29317 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8480851 0.92 CYP2C9 (0.50) PARP1HTTTDP1CYP2C9ROCK2
SCHEMBL7474267 0.84 PARP1 (0.51) PARP1HTTTDP1CYP2C9GRIN2D
SCHEMBL8475992 0.81 ROCK2 (0.53) TDP1CYP2C9ROCK2MAP4K4LCK
SCHEMBL8482604 0.81 CYP2C9 (0.51) PARP1CYP2C9ROCK2MAP4K4LCK
SCHEMBL8476895 0.80 CYP2C9 (0.63) CYP2C9ROCK2MAP4K4LCKCSF1R
SCHEMBL8479093 0.75 CDK2 (0.52) PARP1CYP2C9GRIN2DGRIN3BGRIN1
SCHEMBL8480726 0.75 CYP2C9 (0.55) PARP1CYP2C9ROCK2MAP4K4LCK
SCHEMBL7487055 0.74 CYP2C9 (0.73) CYP2C9ROCK2MAP4K4LCKCSF1R
SCHEMBL8475832 0.74 PIM1 (0.51) CYP2C9ROCK2MAP4K4LCKCSF1R
SCHEMBL8480479 0.73 CYP2C9 (0.49) TDP1CYP2C9GRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1011677-A4 4-ARYL-3-AMINOQUINOLINE-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS BRISTOL MYERS SQUIBB CO (US) 2002-03-20 EP disclosed
EP-1011677-A1 4-ARYL-3-AMINOQUINOLINE-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS Bristol-Myers Squibb Company (US) 2000-06-28 EP disclosed
US-5972961-A ANTIISCHEMIC AGENTS; ANTICONVULSANTS; HEADACHES; SEXUAL DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-10-26 US disclosed
WO-1999009983-A1 4-ARYL-3-AMINOQUINOLINE-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO disclosed